Copyright
©The Author(s) 2024.
World J Diabetes. May 15, 2024; 15(5): 923-934
Published online May 15, 2024. doi: 10.4239/wjd.v15.i5.923
Published online May 15, 2024. doi: 10.4239/wjd.v15.i5.923
Parameter | Group A | Group B | Group C | P value |
FPG (mmol/L) | 6.37 ± 1.43 | 6.40 ± 1.26 | 6.14 ± 1.20 | 0.553 |
White blood cells | 8.84 ± 3.46 | 7.35 ± 1.741 | 5.83 ± 1.352 | 0.000 |
Neutrophils | 6.38 ± 3.66 | 4.97 ± 2.001 | 3.10 ± 1.122 | 0.000 |
Uric acid (µmol/L) | 298.74 ± 71.33 | 294.61 ± 72.68 | 282.76 ± 63.40 | 0.444 |
SBP (mmHg) | 126.37 ± 9.39 | 123.07 ± 10.60 | 124.27 ± 11.15 | 0.272 |
DBP (mmHg) | 75.23 ± 5.84 | 73.76 ± 6.50 | 73.91 ± 4.56 | 0.325 |
PCT (mmol/L) | 0.72 ± 0.95 | 0.36 ± 0.451 | 0.05 ± 0.072 | 0.000 |
HbA1c (%) | 6.74 ± 0.87 | 6.76 ± 0.72 | 6.81 ± 0.52 | 0.855 |
LDL (mmol/L) | 2.29 ± 0.48 | 2.27 ± 0.47 | 2.44 ± 0.46 | 0.141 |
HDL (mmol/L) | 0.83 ± 0.26 | 0.74 ± 0.24 | 0.77 ± 0.22 | 0.136 |
TG (mmol/L) | 2.63 ± 0.70 | 2.51 ± 0.82 | 2.57 ± 0.56 | 0.683 |
TC (mmol/L) | 4.47 ± 0.53 | 4.49 ± 0.70 | 4.43 ± 0.62 | 0.901 |
ABI | 0.76 ± 0.09 | 0.79 ± 0.08 | 0.81 ± 0.082 | 0.032 |
TcPO2 (mmHg) | 35.56 ± 10.13 | 46.32 ± 8.831 | 48.19 ± 8.352 | 0.000 |
Total amputations | 1.23 ± 1.14 | 0.63 ± 0.631 | 0.16 ± 0.372 | 0.000 |
Mortality rate | 4.84% | 0.00% | 0.00% | 0.102 |
Cardiovascular event rate | 8.06% | 0.00%1 | 0.00%2 | 0.020 |
Hospitalization rate | 62.90% | 26.32%1 | 5.45%2 | 0.000 |
Reamputation rate | 58.06% | 28.95%1 | 1.82%2 | 0.000 |
Major amputation rate | 69.35% | 31.58%1 | 36.40%2 | 0.000 |
Minor amputation rate | 53.23% | 31.58%1 | 14.55%2 | 0.000 |
Heal rate | 14.52% | 65.79%1 | 89.09%2 | 0.000 |
Improve rate | 85.48% | 36.84%1 | 10.91%2 | 0.000 |
Ulcer area (cm2) | 3.74 ± 2.04 | 2.68 ± 1.961 | 1.77 ± 1.212 | 0.000 |
Diabetic foot surgery class | 3.01 ± 0.64 | 2.08 ± 0.921 | 1.49 ± 0.962 | 0.000 |
- Citation: Wang XQ, Pu DL, Leng WL, Lei XT, Juan J, La Z, Yao D, Xi JZ, Jian L, Miao T, Wu QN. Efficacy of Huangma Ding or autologous platelet-rich gel for the diabetic lower extremity arterial disease patients with foot ulcers. World J Diabetes 2024; 15(5): 923-934
- URL: https://www.wjgnet.com/1948-9358/full/v15/i5/923.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i5.923